Plain-English translation of NCT07529483 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new treatment approach for pancreatic cysts that cannot be treated with surgery. The study uses gemcitabine and — two cancer-fighting medications — injected directly into the cyst using an ultrasound-guided needle during a procedure. Researchers want to see if this medication can shrink or eliminate these cysts and whether the treatment is safe.
Pancreatic cysts can be concerning because some may develop into cancer, but surgery to remove them is not always possible or safe for every patient. This trial explores a less invasive option that could help people manage these cysts without major surgery.
You likely qualify if…
You likely don't qualify if…
On day one, you will come in for a procedure where doctors use ultrasound guidance to inject the medication directly into your pancreatic cyst. After that, you will have regular follow-up visits every 3 to 6 months (or 6 to 12 months depending on your situation) for at least 3 years, including imaging scans like MRI or CT to see how your cyst is responding. Blood and cyst fluid samples will be collected at certain visits to monitor your progress.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States